Dr. Roach: With severe dementia, medications are of limited benefit
His geriatric doctor said "no" to prescribing medication to help slow down the disease. The doctor said his pulse rate is low ...
'I Treat Patients with Alzheimer’s, and This Is the One Pre-Breakfast Habit I Swear By for Dementia Prevention'
A 2020 study published in Neurology and funded by the National Institute on Aging found that healthy lifestyle ...
Medscape2d
Memantine: A Treatment for Alzheimer's Disease With a New Formulation
In nearly 20 years, aside from cholinesterase inhibitors, memantine is the only drug approved for the treatment of Alzheimer's disease (AD ... memantine's efficacy in treating moderate-to ...
pharmaphorum5d
End looms for Cassava's simufilam in Alzheimer's disease
The Austin, Texas-based biotech revealed that simufilam failed its first phase 3 test in mild-to-moderate Alzheimer's and a second study has now been halted, leading to an 84% drop in its share price.
Business Wire24d
Alpha Cognition Announces a $44 Million Exclusive Licensing Agreement for the Development and Commercialization of ZUNVEYL (benzgalantamine), an FDA-Approved Treatment for Mild ...
ZUNVEYL is a next generation acetylcholinesterase inhibitor approved in the US for the treatment of mild-to-moderate Alzheimer’s disease. Terms of the agreement total $44 million, which includes ...